Boc-Val-Ala-PAB is a protected dipeptide ADC linker intermediate with valine-alanine sequence and para-aminobenzyl spacer, facilitating enzyme-triggered payload release in antibody-drug conjugates. Keywords: ADC linker, protected peptide linker, Val-Ala, cleavable linker, payload release.
Structure of 1884577-99-4
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Boc-Val-Ala-PAB, a synthetic molecule commonly applied in peptide synthesis and drug delivery, carries significant importance in various fields.
Peptide Synthesis: A pivotal component in synthesizing peptides, Boc-Val-Ala-PAB serves as a crucial building block. Acting as a shield for amino acids, it safeguards against unwanted reactions during peptide assembly, ensuring the purity and yield vital for subsequent research and therapeutic usage. This protective role plays a critical part in the synthesis process, guaranteeing the integrity of the peptides formed.
Drug Delivery Systems: Within drug delivery systems, Boc-Val-Ala-PAB plays a dual role in enhancing stability and amplifying the effectiveness of therapeutic compounds. Its integration into prodrugs acts as a shield, safeguarding the active pharmaceutical ingredient until it reaches its intended destination. This integration not only enhances bioavailability but also diminishes the adverse effects associated with medications, offering a more targeted and efficient treatment approach.
Protease Substrate Design: In the realm of studying protease activity, Boc-Val-Ala-PAB plays a pivotal role in substrate design. With a specific sequence tailored for recognition and cleavage by select proteases, it proves invaluable in biochemical assays. This application stands as a cornerstone in unraveling protease functionalities and lays the groundwork for the development of protease inhibitors with potential as pharmaceutical candidates, showcasing its multifaceted utility in research and drug development.
Anticancer Research: Researchers leverage Boc-Val-Ala-PAB as a fundamental linker in crafting antibody-drug conjugates (ADCs). These conjugates fuse antibody-targeting precision with small molecule cytotoxicity, facilitating targeted delivery of anticancer agents specifically to tumor cells. By facilitating controlled drug release, Boc-Val-Ala-PAB maximizes therapeutic efficacy while simultaneously minimizing harm to healthy tissues, underscoring its pivotal role in cutting-edge anticancer research and treatment innovations.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01020 | Boc-Val-Ala-PAB-PNP | 1884578-00-0 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.